Neuroprotective and neurorestorative effects of thymosin β4 treatment following experimental traumatic brain injury.

Abstract

Traumatic brain injury (TBI) remains a leading cause of mortality and morbidity worldwide. No effective pharmacological treatments are available for TBI because all phase II/III TBI clinical trials have failed. This highlights a compelling need to develop effective treatments for TBI. Endogenous neurorestoration occurs in the brain after TBI, including angiogenesis, neurogenesis, synaptogenesis, oligodendrogenesis, and axonal remodeling, which may be associated with spontaneous functional recovery after TBI. However, the endogenous neurorestoration following TBI is limited. Treatments amplifying these neurorestorative processes may promote functional recovery after TBI. Thymosin beta 4 (Tβ4) is the major G-actin-sequestering molecule in eukaryotic cells. In addition, Tβ4 has other properties including antiapoptosis and anti-inflammation, promotion of angiogenesis, wound healing, stem/progenitor cell differentiation, and cell migration and survival, which provide the scientific foundation for the corneal, dermal, and cardiac wound repair multicenter clinical trials. Here, we describe Tβ4 as a neuroprotective and neurorestorative candidate for treatment of TBI.

DOI: 10.1111/j.1749-6632.2012.06683.x
020406020132014201520162017
Citations per Year

65 Citations

Semantic Scholar estimates that this publication has 65 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Xiong2012NeuroprotectiveAN, title={Neuroprotective and neurorestorative effects of thymosin β4 treatment following experimental traumatic brain injury.}, author={Ye Xiong and Asim Khalid Mahmood and Yuling Meng and Yanlu Zhang and Zheng G. Zhang and Daniel C Morris and Michael Chopp}, journal={Annals of the New York Academy of Sciences}, year={2012}, volume={1270}, pages={51-8} }